Baldwin Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Baldwin Investment Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,889	Closed	-$81K	–	178
2018 Q2	$81K	Hold	1,889	–	–	0.03%	169
2018 Q1	$123K	Hold	1,889	–	–	0.04%	107
2017 Q4	$138K	Hold	1,889	–	–	0.05%	109
2017 Q3	$173K	Hold	1,889	–	–	0.07%	107
2017 Q2	$125K	Hold	1,889	–	–	0.05%	106
2017 Q1	$410K	Hold	1,889	–	–	0.16%	85
2016 Q4	$175K	Hold	1,889	–	–	0.07%	118
2016 Q3	$255K	Hold	1,889	–	–	0.11%	110
2016 Q2	$191K	Hold	1,889	–	–	0.08%	116
2016 Q1	$309K	Hold	1,889	–	–	0.13%	96
2015 Q4	$619K	Hold	1,889	–	–	0.28%	56
2015 Q3	$609K	Hold	1,889	–	–	0.27%	58
2015 Q2	$753K	Hold	1,889	–	–	0.31%	52
2015 Q1	$930K	Hold	1,889	–	–	0.37%	46
2014 Q4	$676K	Buy	1,889 +556	+42%	+$165K	0.26%	60
2014 Q3	$257K	Hold	1,333	–	–	0.11%	121
2014 Q2	$319K	Hold	1,333	–	–	0.14%	103
2014 Q1	$341K	Hold	1,333	–	–	0.15%	100
2013 Q4	$264K	Hold	1,333	–	–	0.12%	116
2013 Q3	$225K	Hold	1,333	–	–	0.11%	120
2013 Q2	$237K	Buy	+1,333	New	+$189K	0.12%	109

Other funds holding LUMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baldwin Investment Management's LUMO Position: Q3 2018 in Review

Baldwin Investment Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2018, closing a stake of 1,889 shares — an estimated $81K sold.

Baldwin Investment Management first reported a position in LUMO in Q2 2013 and held it in 21 quarters. The position peaked at $930K in Q1 2015. 92 funds tracked by Wall St. Rank hold LUMO as of Q3 2018.

Baldwin Investment Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Baldwin Investment Management sold 1,889 Lumos Pharma, Inc. Common Stock shares in Q3 2018, an estimated $81K.
Baldwin Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 21 quarters.
Baldwin Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $930K in Q1 2015.
92 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2018.

Based on Baldwin Investment Management's 13F filing for Q3 2018, filed 9 Nov 2018.